Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.36NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.44NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
LT.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.8.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
LV.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.54.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.30.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KP.1.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
MN.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.63NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
LE.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
LH.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HW.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.55.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.18.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDK.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KP.3.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KP.2.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
LS.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.1 (Omicron)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4 (Omicron)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.15NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.6.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.43.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.50 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.266NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.253NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.305NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.241NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.326NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.558NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used